A study in the January 2025 issue of The Spine Journal reveals that venture capital investors invested $5.3 billion in the spine surgery industry from 2000 to 2023. Researchers analyzed 1,001 investments across 227 companies, categorizing them into surgical devices, noninvasive devices, biotechnology, surgical software, and clinical services. Non-surgical devices received the largest share at 42.6%, followed by surgical devices at 26.3% and biotechnology at 22.2%. Although annual investments surged by 1,782%, a decline occurred in 2023, attributed to macroeconomic factors.